Determinination of the Frequency of Altered Cardiac Repolarization by Measuring the Heart rate Corrected QT Interval in COPD Patients
Journal of Pharmaceutical Research International,
Objectives: To determine the frequency of altered cardiac repolarization by measuring the heart rate corrected QT interval in COPD patients.
Setting: Department of Medicine at LUMHS hospital Hyderabad/Jamshoro.
Study Design: Descriptive Cross sectional study.
Duration of Study: 6 months from 01-03-2019 to 31-08-2019.
Methods: A total of 232 patients with severe acute exacerbation of COPD were included in this study. A 12 lead ECG was performed. QT intervals were measured on a resting ECG tracing in lead II. The QT interval was measured manually from the starting point of the QRS complex to the terminal point of the down slope of the T wave.
Results: A total of 232 patients with COPD were included in this study. Most of the cases were above 50 years of age. The average age of the patients was 53.74±4.35 years. There were 92.67% (215/232) male and 7.33% (17/232) female. Out of 232 patients, 21.14% were current smoker and 75.86% were ex-smoker. A QTc interval >0.44 seconds was considered abnormally prolonged. Frequency of altered cardiac repolarization by measuring the heart rate corrected QT interval in COPD patients was 31.47% (73/232). Rate of altered cardiac repolarization was not significant among different age groups (p=0.641). Rate of altered cardiac repolarization was significantly high in male as compare to female (33.5% vs. 5.9%; p=0.018). This was not significant between obese and non-obese groups (p=0.100). Rate of altered cardiac repolarization was significantly high in former smoker (p=0.0005) and those patients whose duration of COPD was above 15 years (p=0.0005).
Conclusion: Patients with hypoxic chronic obstructive pulmonary disease (COPD) have evidence of a subclinical parasympathetic autonomic neuropathy, with apparent preservation of sympathetic function. Measuring heart rate corrected QT interval (QTc) test is repeatable, easy to perform and a sensitive indicator for autonomic dysfunction in breathlessness individuals with COPD.
- Chronic obstructive pulmonary disease
- QT interval
- Altered cardiac repolarization
How to Cite
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582.
Fu SN, Yu WC, Wong CK, Lam MC. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting. Int J Chron Obstruct Pulmon Dis. 2016; 11:2391–2399.
Axson, E.L., Ragutheeswaran, K., Sundaram, V. et al. Hospitalisation and mortality in patients with comorbid COPD and heart failure: A systematic review and meta-analysis. Respir Res. 2020;21, 54.
Gupta AS, Rajesh V, James P. Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease – a hospital-based study. Egypt J Bronchol. 2019;13, Suppl S1:591-5.
Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice?. Ther Adv Respir Dis. 2018;12:1-16.
McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007,62:411–5.
André S, Conde B, Fragoso E, Boléo-Tomé JP, Areias V, Cardosog J. COPD and Cardiovascular Disease Pulmonol. 2019;25(3):168-76.
Clarenbach CF, Senn O, Sievi NA, Camen G, van Gestel AJ, Rossi VA, et al. Determinants of endothelial function in patients with COPD. EurRespir J. 2013; 42:1194–204.
Sin DD, Man SF: Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8–11.
Elming H, Brendorp B, Kober L, Sahebzadah N, Torp-Petersen C: QTc interval in the assessment of cardiac risk. Card Electro physiol Rev. 2002;6:289–94.
Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–67.
Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Prog Cardiovasc Dis. 2001;43:1–45.
Sievi NA, Clarenbach CF, Camen G, Rossi VA, Gestel AJ and Kohler M. High prevalence of altered cardiac repolarization in patients with COPD. BMC Pulmonary Medicine. 2014;14(1):1-8.
Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10:81-9.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systemic review and meta-analysis. EurRespir J. 2006; 28:523-32.
Arsalan A, Shad Z, Sabah A, Ahmed FR, Malik A, Shakeel O. Prevalence and therapy of chronic obstructive pulmonary disease in Karachi. IJPTP. 2014;5:867-904.
Lazarus RS, DeLongis A. Psychological stress and coping in aging. American Psychologist.1983;38(3):245–54.
Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.
Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The Prevalence of COPD using smoking rates to estimate disease frequency in the general population. Chest. 2000;117:354S-9S.
National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(1):1- 232
Abstract View: 0 times
PDF Download: 0 times